Chronic Lower Back Pain Global Market Report 2024

Description

“Chronic Lower Back Pain Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic lower back pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic lower back pain? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The chronic lower back pain market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type of Pain: Diskogenic Pain; Lumbar Spinal Stenosis; Sacroiliac Pain; Facet-Joint Pain; Radicular Pain; Muscular Pain; Other Types Of Pain
2) By Diagnosis: Clinical History; Physical Examination; Imaging Guidelines; Assessment of Pain
3) By End-User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End-Users
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Private Limited; Sanofi S.A.; Endo Pharmaceuticals plc; Merck Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Chronic low back pain (CLBP) characterizes pain persisting for 12 weeks or more, despite treatment aimed at resolving the initial cause or acute episode of low back pain. This condition represents a major contributor to disability and often gives rise to psychological issues such as stress, depression, and anxiety.

The primary types of chronic lower back pain encompass discogenic pain, lumbar spinal stenosis, sacroiliac pain, facet-joint pain, radicular pain, muscular pain, and other variants. Discogenic pain specifically originates from damage to spinal discs, commonly associated with conditions such as degenerative disc disease, which occurs naturally as part of the aging process. Diagnosis typically involves a comprehensive clinical history, physical examination, imaging assessments, and pain evaluation. Treatment is administered across various healthcare facilities, including hospitals, orthopedic clinics, ambulatory surgery centers, among others.

The chronic lower back pain market research report is one of a series of new reports from The Business Research Company that provides chronic lower back pain market statistics, including chronic lower back pain industry global market size, regional shares, competitors with a chronic lower back pain market share, detailed chronic lower back pain market segments, market trends and opportunities, and any further data you may need to thrive in the chronic lower back pain industry. This chronic lower back pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic lower back pain market size has grown strongly in recent years. It will grow from $7.3 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth observed in the historical period regarding chronic low back pain (CLBP) can be attributed to several key factors. These include the prevalence of sedentary lifestyles leading to increased susceptibility to back issues, occupational risks and manual labor often causing strains and injuries, advancements in medical diagnosis aiding in better identification of CLBP, the evolution of pain management strategies contributing to improved treatment options, and the insights gained from epidemiological studies that enhanced our understanding of this condition. These factors collectively contributed to the growth and understanding of chronic low back pain during that period.

The chronic lower back pain market size is expected to see steady growth in the next few years. It will grow to $9.27 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. Anticipated growth in the forthcoming period regarding chronic low back pain (CLBP) can be attributed to several factors. These include the increased adoption and emphasis on non-pharmacological interventions for managing CLBP, the implementation of preventive healthcare initiatives aimed at addressing back-related issues before they escalate, a greater focus on holistic treatments encompassing various aspects of well-being, ongoing advancements in regenerative medicine offering promising solutions, and the demographic trend of an aging population more prone to such conditions. Key trends expected in the forecast period include a heightened emphasis on non-pharmacological interventions as a primary approach for managing CLBP, a notable shift in pain management strategies to incorporate a wider range of treatments, increased healthcare awareness and education regarding CLBP prevention and management, the utilization of telemedicine and remote monitoring for efficient patient care, and the integration of regenerative medicine approaches into the treatment spectrum for chronic low back pain.

The chronic lower back pain market is expected to witness growth driven by an increase in the frequency of nerve instances. In this context, nerve instances refer to specific occurrences where individuals display bravery, courage, or resilience in challenging situations. Continuous exposure to stress and pain can lead to central sensitization, a phenomenon where the nervous system becomes hypersensitive, intensifying the perception of pain even in the absence of actual injury. As reported by Nature in July 2023, the prevalence of peripheral neuropathy, associated with nerve damage, is 28.4% in adults aged 40 or older with diabetes and 11.8% in those without diabetes. The rising frequency of nerve instances contributes to the growth of the chronic lower back pain market.

The growth of the chronic lower back pain market is further propelled by the increasing geriatric population. The term 'geriatric population' refers to individuals aged 65 and above. Among this demographic, age-related neurodegenerative and musculoskeletal conditions such as arthritis and osteoarthritis progress rapidly, leading to weakness and painful complaints resulting in chronic back pain and reduced physical activities. According to data released by the World Trade Organization in October 2022, the proportion of the global population aged 60 and above increased from 1 billion to 1.4 billion from 2020 to 2021. By 2050, the world's population of adults aged 60 and above is projected to double to 2.1 billion, with the number of people aged 80 or more predicted to triple between 2020 and 2050, reaching 426 million. The growth in the geriatric population is a significant driver for the chronic lower back pain market.

Technological advancements emerge as a key trend gaining popularity in the chronic lower back pain market. Major companies within this market are actively involved in developing new and improved advanced technologies for the treatment and prevention of lower back pain to maintain their competitive positions. In December 2022, Abbott Laboratories, a US-based medical devices and healthcare company, introduced the Eterna spinal cord stimulation (SCS) device. Recognized as the world's smallest implantable, rechargeable spinal cord stimulator for treating chronic pain, the Eterna SCS device, featuring Abbott's low-dose BurstDR stimulation technology, has received approval from the US Food and Drug Administration (FDA). This technological innovation demonstrates the commitment of major companies to advancing the treatment options for chronic lower back pain.

Major companies in the chronic lower back pain market are actively engaged in the development of products incorporating advanced technologies, such as BurstDR SCS technology, to introduce innovative options for patients. BurstDR SCS technology is a proprietary therapy within the spinal cord stimulation (SCS) category, employing mild electrical pulses to modify pain signals during their transmission from the spinal cord to the brain. An illustration of this technological advancement is evident in the case of Abbott Laboratories, a prominent US-based medical device company. In May 2023, Abbott Laboratories received approval from the US Food and Drug Administration (FDA) for its Spinal Cord Stimulation (SCS) devices, which include the Proclaim SCS Family and Eterna SCS System specifically designed for treating chronic back pain. Abbott's SCS devices utilize the proprietary BurstDR stimulation waveform, offering a superior therapy that closely replicates the pathway of pain signals to the brain, effectively addressing the emotional aspects associated with pain. This stands in contrast to traditional tonic stimulation methods.

In September 2022, The National Science Foundation (NSF), an independent US-based agency focusing on fundamental research and education in science, collaborated with a multidisciplinary team led by researchers at the University of California, San Diego. This collaboration involved a substantial investment of $1.2 million and aimed to study and advance the treatment of chronic low back pain. The research initiative focuses on implementing remote monitoring of patients' posture and mobility throughout the day, facilitating individualized physical therapy treatments to optimize health outcomes. This collaborative effort underscores the commitment to leveraging technology and interdisciplinary research to enhance the understanding and management of chronic lower back pain.

Major companies operating in the chronic lower back pain market report are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy's Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc. .

North America was the largest region in the chronic lower back pain market in 2023. The regions covered in the chronic lower back pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chronic lower back pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic low back pain market includes revenues earned by entities by providing low back pain treatment services such as pain management services, and neuropathic and nociceptive pain management. Establishments that provide long treatment plans and management services are included in this market. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r10840

1. Executive Summary

2. Chronic Lower Back Pain Market Characteristics

3. Chronic Lower Back Pain Market Trends And Strategies

4. Chronic Lower Back Pain Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Chronic Lower Back Pain Market Size and Growth

5.1. Global Chronic Lower Back Pain Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Chronic Lower Back Pain Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Chronic Lower Back Pain Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chronic Lower Back Pain Market Segmentation

6.1. Global Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diskogenic Pain
Lumbar Spinal Stenosis
Sacroiliac Pain
Facet-Joint Pain
Radicular Pain
Muscular Pain
Other Types Of Pain
6.2. Global Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinical History
Physical Examination
Imaging Guidelines
Assessment of Pain
6.3. Global Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Orthopaedic Clinics
Ambulatory Surgery Centres
Other End-Users

7. Chronic Lower Back Pain Market Regional And Country Analysis

7.1. Global Chronic Lower Back Pain Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Chronic Lower Back Pain Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chronic Lower Back Pain Market

8.1. Asia-Pacific Chronic Lower Back Pain Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chronic Lower Back Pain Market

9.1. China Chronic Lower Back Pain Market Overview
9.2. China Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chronic Lower Back Pain Market

10.1. India Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chronic Lower Back Pain Market

11.1. Japan Chronic Lower Back Pain Market Overview
11.2. Japan Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chronic Lower Back Pain Market

12.1. Australia Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chronic Lower Back Pain Market

13.1. Indonesia Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chronic Lower Back Pain Market

14.1. South Korea Chronic Lower Back Pain Market Overview
14.2. South Korea Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chronic Lower Back Pain Market

15.1. Western Europe Chronic Lower Back Pain Market Overview
15.2. Western Europe Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chronic Lower Back Pain Market

16.1. UK Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chronic Lower Back Pain Market

17.1. Germany Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chronic Lower Back Pain Market

18.1. France Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chronic Lower Back Pain Market

19.1. Italy Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chronic Lower Back Pain Market

20.1. Spain Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chronic Lower Back Pain Market

21.1. Eastern Europe Chronic Lower Back Pain Market Overview
21.2. Eastern Europe Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chronic Lower Back Pain Market

22.1. Russia Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chronic Lower Back Pain Market

23.1. North America Chronic Lower Back Pain Market Overview
23.2. North America Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chronic Lower Back Pain Market

24.1. USA Chronic Lower Back Pain Market Overview
24.2. USA Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chronic Lower Back Pain Market

25.1. Canada Chronic Lower Back Pain Market Overview
25.2. Canada Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chronic Lower Back Pain Market

26.1. South America Chronic Lower Back Pain Market Overview
26.2. South America Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chronic Lower Back Pain Market

27.1. Brazil Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chronic Lower Back Pain Market

28.1. Middle East Chronic Lower Back Pain Market Overview
28.2. Middle East Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chronic Lower Back Pain Market

29.1. Africa Chronic Lower Back Pain Market Overview
29.2. Africa Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chronic Lower Back Pain Market Competitive Landscape And Company Profiles

30.1. Chronic Lower Back Pain Market Competitive Landscape
30.2. Chronic Lower Back Pain Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson Private Limited
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Sanofi S.A.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Endo Pharmaceuticals plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Merck Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Chronic Lower Back Pain Market Competitive Benchmarking

32. Global Chronic Lower Back Pain Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Chronic Lower Back Pain Market

34. Chronic Lower Back Pain Market Future Outlook and Potential Analysis

34.1 Chronic Lower Back Pain Market In 2028 - Countries Offering Most New Opportunities
34.2 Chronic Lower Back Pain Market In 2028 - Segments Offering Most New Opportunities
34.3 Chronic Lower Back Pain Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer